Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIb/IV, Multi-centre, Double-blind, Randomised, Placebo-controlled Parallel Group Study to Compare the Efficacy and Safety of Movicol® With Placebo in Patients With Constipation Associated With Irritable Bowel Syndrome (IBS)

NCT00796354 is registered in ClinicalTrials.gov with Norgine as lead sponsor.

NCT NCT00796354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIb/IV, Multi-centre, Double-blind, Randomised, Placebo-controlled Parallel Group Study to Compare the Efficacy and Safety of Movicol® With Placebo in Patients With Constipation Associated With Irritable Bowel Syndrome (IBS)
Lead sponsor
Norgine
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
February 28, 2010
Enrollment
210 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

constipation